Last Price
24.29
Today's Change
+21.80 (875.86%)
Day's Change
2.49 - 31.50
Trading Volume
87,885,317
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Ian McDonald Mr. Ian McDonald
Full Time Employees: 0 0
IPO Date: 2021-03-22 2021-03-22
CIK: 0001827401 0001827401
ISIN: CA10919W4056 CA10919W4056
CUSIP: 10919W108 10919W108
Beta: 1.73 1.73
Last Dividend: 0.00 0.00
Dcf Diff: 22.08 22.08
Dcf: 1.30 1.30
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.